COVID-19: New adaptation for IVF laboratory protocols.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) widely known as COVID-19 was first reported in late December 2019, in China. Since then this novel coronavirus has spread throughout the world. Our return to normal life will not take long, for we are in a phase where the COVID-19 curve is stabilizing. ART services must return to operation, since infertility is also a disease and treatment has to start. Before resuming ART treatments, it is very important to consider local and national regulations. Change is mandatory, to set us back to successful ART treatment without compromising on quality, and to minimize the spread of COVID-19 among staff and patients; and for this we need to take measured and vigilant steps.
['Andrabi|Syed Waseem|SW|', 'Jaffar|Mir|M|', 'Arora|Puneet Rana|PR|']
D000073640:Betacoronavirus D000086382:COVID-19 D018352:Coronavirus Infections D005307:Fertilization in Vitro D006801:Humans D058873:Pandemics D011024:Pneumonia, Viral D027724:Reproductive Techniques, Assisted D000086402:SARS-CoV-2
COVID-19 new adaptations IVF laboratory